ABSTRACT
INTRODUCTION
It is estimated that every year more than 800,000 coronary artery bypass graft (CABG) procedures are performed worldwide. Although most of these procedures utilize at least one arterial graft, the reversed saphenous vein remains the most widely used conduit for coronary revascularization. Despite their central role in coronary surgery, however, saphenous vein grafts have a distinctly higher failure rate than artery grafts. Compared with the excellent 96% one-year [1] and 83%-93% ten-year patency of internal thoracic artery (ITA) grafts [2, 3] , historical series of saphenous vein grafts from the 1970s and early 1980s reported sobering patencies of 41-71% for the same implantation period [4, 5] . More recent studies were only marginally better with 56-69% [6] . This difference in long term patency between arterial and vein grafts is not only reflected in quality of life but also in patient survival [7] .
As such, improving the long-term performance of saphenous vein grafts in coronary bypass surgery would distinctly affect re-occurrence of angina, re-operation or re-intervention rates, effort tolerance and life expectancy.
The main cause of intermediate to late vein graft failure is attributable to progressive neointimal hyperplasia with subsequent superimposed arteriosclerosis [8] . Autopsy series demonstrated that as early as after 6 months of implantation, diffuse intimal hyperplasia begins to appear in most of the vein grafts [5, 9, 10] . Beyond 12 months diffuse intimal hyperplasia either remains static or progresses and develops more focally [4, 9] . Between 6 and 10 years, two thirds of grafts show focal stenoses of between 50% and 75% [5, 9] . As more than 90% of lesions leading to mid-term failure were detectable within the first year, early intimal hyperplasia was shown to be the main reason for mid-to long-term failure [11] .
Conversely, no late occlusions were found in grafts without diffuse or localized intimal hyperplasia present at 1-6 months [8] . Therefore, suppression of intimal hyperplasia holds a key to improved mid-to long-term performance of vein grafts.
Amongst factors such as harvest-related endothelial trauma [12] , biomechanical and fluid dynamic forces such as wall tension [13] and low shear stress [14] were shown to be main triggers of neo-intimal hyperplasia in vein grafts. High-flow run off into large-diameter coronary arteries, for instance, resulted in a 10-year patency of 88% as opposed to 55% seen in low-flow conduits to small-diameter arteries [6] . Similarly, low flow conditions similar to those resulting from the diameter mismatch between large vein grafts and small run-off arteries were shown to cause significant neointimal hyperplasia [15] . Experimentally, the reverse principle could also be demonstrated: by using external meshes to constrict femoral vein grafts [16] [17] [18] or carotid interposition grafts [19] that were too large in diameter for their run-off arteries, intimal hyperplasia could be almost completely suppressed.
In view of the distinctly different remodelling behaviour of infra-inguinal and coronary vein grafts [20] , however, it remained unclear whether mesh constriction would be equally effective in coronary bypass surgery. While the relatively small dimensions of coronary arteries do not allow the same degree of calibre adjustment of the vein grafts as in femoral grafts, baseline shear forces are more protective in the coronary than femoral circulation [20] .
We therefore investigated the mitigating effect of mesh constriction on intimal hyperplasia in coronary bypass grafts using a senescent primate model. showing a retracted vein-end that had invaginated as the mesh-supported fibrin glue layer was mistaken for the vein end. Subsequently, the initial fibrin spraying was applied to taper out towards the proximal end of the graft allowing a separate anastomosis of the straight-cut vein and the mesh to the aorta. Re-cutting of the distal end at an angle permitted the clear identification of the vein and as such, the mesh was continued to be included in the LADanastomosis although the wide-spaced mesh-loops led to only a few of the anastomotic stitches incorporating the mesh in the suture line. These 'terminal' loops all bent slightly outward towards the epicardium excluding the possibility of causing luminal encroachment.
MATERIALS AND METHODS

Nitinol
After completion of the proximal vein graft anastomosis the unattached mesh was briefly slipped back towards the middle of the graft (±2cm) and the cross-clamp was intermittently opened to allow the measurement of the outer diameter (OD) of the distended vein graft without Nitinol mesh support. After a few attachment stitches were placed through the terminal mesh-loops a thin layer of fibrin sealant was also sprayed onto the proximal end of the graft. Competitive flow was prevented by obliterating the LAD 2cm proximal of the distal anastomotic site with an external pledgeted mattress stitch (4-0 Prolene) followed by probing with a 1mm probe.
Graft Retrieval
All animals were euthanized after 180 days. Subsequently, perfusion fixation was used at 120mmHg to preserve luminal in-vivo dimensions in order to counteract the recoil tendency of non-pressurized blood vessels and the recoil force integrated into the knitted Nitinol mesh (1L of 10% formalin in PBS; iliac cannulation). After no less than 2 hours of pressure fixation the hearts were resected en bloc and transferred to the hospital for post-mortem angiographic assessment. With the aorta clamped proximally and distally to the graft, nonionic Iopromide contrast medium (e.g. Ultravist® 300) was motor injected with the specimen in postero-anterior as well as a right anterior oblique position. Subsequently, 100ml 0.9% NaCl solution was injected followed by Formalin, followed by immersion fixation in 10% formalin for at least another 24 hours. Then, the en-bloc specimens underwent faxitron analysis (Faxitron MX20; Faxitron X-ray Corporation, IL) using a 35KV setting to assess the integrity of the Nitinol mesh at explantation. Subsequently, a 15mm long cross-section specimen was centrally excised for macroscopic image analysis prior to embedding in paraffin (groups 1 and 2) or resin (group 3). Adjacent ring-segments were longitudinally opened and processed for macroscopic assessment and scanning electron microscopy.
Macroscopic Graft Dimensions
Luminal dimensions of implanted vein grafts were calculated on the basis of ODs and the wall thicknesses of control samples [16, 17] . In the absence of intra-operative angiography facilities, the ID of the LAD at implantation was approximated through gentle insertion of probes with incremental quarter-millimeter diameter steps into the proximal stump.
Macroscopic image analysis of midgraft sections QWinPro (V2.5; Leica Microsystems Imaging Solutions) was used in conjunction with post-mortem explant-angiography performed at Groote Schuur Hospital (University of Cape Town).
The degree of dimensional mismatch between vein grafts and host arteries was expressed as the quotient of cross sectional areas (Q c = a h /a g whereby a h represented the cross sectional area of the host artery and a g that of the interposition graft).
Histology
Three routine stains haematoxylin and eosin (H&E), modified Elastic Masson trichrome and modified Movat were used for light microscopy (Nikon E1000M; Nikon, Tokyo). Two series of consecutive 3m sections (approximately 300m apart) were cut and analysed. For immunofluorescence, VWF (vonWillebrand factor) and -actin (Abcam,Cambridge,UK) stains were combined with nuclear counter-stains (Dapi; Invitrogen Molecular Probes, Carlsbad, USA) and viewed under a Nikon 90i microscope (Nikon, Tokyo Japan).
For resin histology, mid-graft sections were infiltrated with methyl-methacrylate resin (MMA) (Sigma-Aldrich, Steinheim, Germany) [16, 17] and cut on a Leica Polycut using a tungsten carbide blade. Then the resin was removed with 2-methoxyethylacetate to enable staining [21] .
Microscopic Image Analysis
Composite images were assembled from digital single-frames (Nikon Eclipse 90i) and analysed using Eclipse Net (Laboratory Imaging, Prague, Czech Republic) software. The neo-intimal tissue intimal hyperplasia tissue (IH) was easily discernable by its typical loose arrangement of SMCs embedded in abundant extracellular matrix and often additionally by a demarcating internal elastic membranes (IEM). Graft shrinkage or dilatation was assessed on the basis of 'sub-intimal diameters' (SIDs).
Scanning Electron Microscopy
After critical point drying (CPD7501, Polaron, Watford, UK) of specimens that were postfixed in 2% glutaraldehyde (GA) they were viewed in a JEOL JSM5200 (Jeol, Tokyo, Japan).
Scanning electron microscopy (SEM) images were digitally captured by Orion V5.20 software (Orion, Brussels, Belgium) at 15x magnifications. Scion Image Software (NIH, Bethesda, USA) was used for the quantification of surface endothelialization
Statistical Analysis
Patency data were compared using Fisher's exact test. For between-group comparisons one way ANOVA (overall p=0.0006) followed by post hoc Tukey-Kramer HSD test were applied using 'Statistics' (JMP version 10, SAS, Cary, NC). Normal distribution was confirmed by the Shapiro-Wilk test. Two-tailed p values < 0.05 were regarded as demonstrating statistical significance.
RESULTS
In both control groups 1/6 grafts were occluded while all mesh-supported grafts (6/6) were patent after 180 days of implantation.
Graft Pathology
Upon explantation, control grafts -either untreated or sprayed with fibrin sealant-were thickwalled with irregular luminal diameter. In contrast, mesh supported grafts were delicate and thin walled with even luminal dimensions (Figure 2 ). While the wall thickness had increased by 363±39% (p<0.00001) in the untreated controls and 312±61% in the fibrin-sprayed control group (p<0.00001) it was only 82±61% in the mesh supported group (p<0.007).
Compared to mesh-supported grafts the wall thickness at explantation was 2.3 times thicker in controls (p<0.00001) and 2.0 times thicker in fibrin-sprayed controls (p<0.0001).
All grafts had a glistening, thrombus-free blood surface [endothelial coverage 91±12% (CO); 75±22% (CO+FS) and 92±8% (ME+FS) (NS)]. In mesh-constricted grafts the tissue layer between the mesh and the endothelium was mostly so delicate that the relief of the mesh was recognizable on the inner surface (Figure 3) .
In all control grafts concentric, thick neo-intimal tissue was present [600±63m (CO) and 627±204m (CO+FS); N.S. (Fig 5) . In contrast, IH was distinctly less pronounced and typically eccentric in the mesh-supported grafts [249±83m; CO vrs ME+FS p=0.002; CO+FS vrs ME+FS p=0.001 (Figure 4; 5) . The data were normally distributed (confirmed by Shapiro-Wilk test). Related to intimal thickness at the time of implantation it had increased by 298±42% in controls and 315±135% in fibrin-sprayed controls but only 65±54% in the mesh-constricted group (p<0.003 versus both control groups). Compared to meshconstricted grafts, the cross sectional area of neo-intimal tissue was 155% larger in controls (p<0.0005) and 152% in fibrin-sprayed controls (p<0.001). IH accounted for 56±6% of the total wall thickness in non fibrin-treated grafts; 66±14% in fibrin-treated grafts and 59±4% in mesh-supported grafts with no significant difference between any of the groups. The faxitron analysis showed that only 1/6 grafts showed mild signs of wire breakage ( Figure   7 ).
Luminal Dimensions
DISCUSSION
Using a senescent, non-human primate model we could demonstrate that external constriction of coronary vein grafts with a knitted Nitinol meshes suppresses intimal hyperplasia and prevents the formation of localised luminal narrowings. After 180 days of implantation control grafts showed thick layers of neo-intimal tissue as opposed to the largely delicate neo-intima found on mesh-constricted grafts. Moreover, luminal irregularities in control vein grafts -varying between extended segments of narrowing and sometimes ectatic areas-were opposed by a relatively constant inner diameter in mesh-sheathed grafts.
Although the vascular tissue response in senescent Chacma Baboons is still less deferred than in humans it has previously been shown to reflect vascular injury and remodelling better than other animal models [22, 23] . As such, a half-year observation period is likely to correspond [22] with the mid-term graft failure period of clinical coronary artery bypass grafts. Since a majority of clinical graft failures occurring beyond the first year have been shown to be attributable to pre-existing diffuse or localised intimal hyperplasia [8] , it seems justified to project the results of the present study to the clinical mid-to long-term performance of meshconstricted vein grafts.
However, while the suppression of neo-intimal tissue formation was still distinct and significant, it was less pronounced than in previously implanted infra-inguinal grafts using the same animal model. In contrast to the near complete abolition of IH in the infra-inguinal model, mesh-constricted coronary vein grafts regularly showed thin but clearly discernable areas of IH along the inner circumference. Apart from different flow patterns [20] the main difference between infra-inguinal and coronary bypass grafts is the degree of calibre mismatch between the vein grafts and target arteries.
In the senescent Chacma baboon, this calibre mismatch between coronary vein grafts and the LAD is 3.6 times that of infra-inguinal grafts, resulting in a cross sectional quotient (Qc) of 0.16 as opposed to 0.62. Calibre-mismatched vein grafts that are larger than their target arteries experience flow deceleration. Notwithstanding differences of flow patterns, pulse volumes and run-off at different anatomical sites, the lower shear stress resulting from this flow deceleration is known to trigger intimal hyperplasia and graft shrinkage [20, 24] .
Corresponding with the more pronounced calibre mismatch in coronary vein grafts, the maximum flow velocity was found to be 58% and the mean velocity 62% lower than in femoral vein grafts [20] . As such, the resulting mean shear stress was shown to be 2.4 dynes/cm 2 in coronary vein grafts as opposed to 5.8 dynes/cm 2 in infra-inguinal grafts using the same saphenous vein as a conduit [20] . The threshold for the suppression of intimal hyperplasia had been estimated to be 5 dynes/cm 2 [25] . In a previous study we concluded that the threshold cross sectional quotient for the complete suppression of IH seemed to be at a Qc>0.45 [16] . Given the fact that a 3.4mm mesh constriction of baboon coronary vein grafts only partially mitigated their calibre mismatch with the LAD from a Qc of 0.18 to a Qc of 0.41 it seems plausible that 5dynes/cm 2 were only marginally reached. In contrast, a similar constriction of infra-inguinal vein grafts with 3.4mm ID meshes allowed even an overcorrection of the calibre mismatch to a Qc>1. The resulting high shear forces were unequivocally suppressive for IH [16, 17] . The diameter of a coronary vein graft that corresponds with this degree of adaptive constriction would have needed to be <1.8mm ID.
Such small diameters are not a problem per se. As internal thoracic artery grafts show, small diameters are ideal if they can be achieved through the use of naturally occurring arteries.
The much larger vein grafts, though, have limits of diameter constriction. While most surgeons would have a high threshold towards using a vein graft of <3mm diameter, there are also handling issues and aspects of vein redundancy. Although we have previously shown that longitudinal pleating of the Nitinol mesh allows significant down-sizing of the cross sectional area without reduction of the circumference [17] and as such would take care of the excess of vein wall relative to the small diameter, there are limits of diameter reduction when it comes to the atraumatic insertion of longer veins into the mesh. As the insertion resistance increases with decreasing mesh diameter, the post-insertion retraction forces increase. As a consequence, the vein end may retract under the cover of the thin layer of fibrin sealant used for the attachment of the mesh. If the suture of the aortic anastomosis mistakes the fibrin for the vein, acute inflow occlusions of the graft are possible. Therefore, after a short learning curve, we took care of re-cutting the mesh to align it with the vein graft end. Moreover, mesh-constricted vein grafts have a low tolerance towards additional luminal encroachment.
Therefore, side branches were cut-off and over-sewn with 7-0 Prolene to prevent the ligated stumps from compressing the vein. In a study of 39 human saphenous veins inserted in 3.4mm meshes the luminal encroachment by ligated branches was more than 40%
(manuscript in preparation). This distinct additional narrowing of a lumen that had already been reduced by almost 40% through the mesh constriction was the obvious reason for a dismal 9-month patency of 28% in a clinical pilot study [26] .
However, while distinctly smaller mesh sizes would be required to achieve completely suppressive shear forces in baboons coronary vein grafts, constriction with an identical 3.4mm mesh would likely achieve these forces in humans where the diameter of the saphenous vein is 15% smaller and that of the LAD 38% larger than in baboons [20, 27] . As such, a 3.4mm(ID) mesh that only led to an increase in Qc from <0.20 to 0.41 in the present study would have achieved a Qc of >0.6 under clinical circumstances [16] .
Apart from the remodelling behaviour of the sheathed vein grafts, the meshes themselves behaved differently in the coronary compared to the infra-inguinal position. While 63% of meshes had shown local signs of wire breakage in patent infra-inguinal vein grafts [18] , only one out of 6 mesh-constricted coronary grafts showed any wire breakage in the present study, restricted to a few single struts in the area of strongest graft bending. The differences between the previously investigated femoral and the present coronary locations were three-fold: for one, the inserted vein was the saphenous vein in the coronary position while it was the significantly larger femoral vein in infra-inguinal grafts. However, since we have previously
shown that saphenous veins dilate under femoral flow conditions [20] while having an even thinner wall thickness than femoral veins [16] , this difference seems unlikely to be the reason for the wire breakages. Alternatively, one could argue that the breakages all happened in a mechanically strained area as opposed to the protected anatomy behind the sternum. Yet, the fact that breakages only happened in patent grafts makes this explanation unlikely to be a single-factor cause of material tiring. Lastly, differences in pulse volume and amplitude could account for higher wire-stress in femoral position. Alternatively, a combination of all three factors could be the case.
In conclusion, we could show in a senescent non-human primate model that constrictive, external mesh support of saphenous vein grafts with knitted Nitinol suppresses neo-intimal tissue proliferation in coronary artery bypass grafts by a factor 2.5. Although distinct and significant, this was clearly less pronounced than the mitigation of intimal hyperplasia by a factor 8.9 which we had previously observed in the high-flow and better diameter-adapted infra-inguinal position [18] . However, the milder calibre mismatch between saphenous veins and the coronary arteries in humans makes it likely that the effect of mesh constriction on coronary vein grafts will be more pronounced when clinically applied. Notwithstanding, even the more moderate mesh-effect observed in the present study resulted in a clear outcome with regards to larger and constant luminal graft dimensions and the mitigation of focal and diffuse intimal hyperplasia. The fact that the meshes showed hardly any signs of wire breakage should alleviate previous concerns. 
